[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-162153-105":53,"doc-detail-162153-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","patient-drug-interactions-handout-and-wallet-card","Patient Drug Interactions Handout and Wallet Card","","Provides a protocol appendix workflow for creating a Patient Drug Interactions Handout and a wallet-sized Drug Interaction Wallet Card for clinical trials involving non-marketed investigational agents with potential drug interactions. Defines authorship responsibilities (CTEP PMB for CTEP IND studies; lead protocol organization otherwise), required site completion of patient-specific fields, and the need for IRB approval prior to patient distribution. Includes templates and patient-facing instructions to identify interacting medicines, herbal supplements, strong inducers/inhibitors or QTc prolongation risk, and specifies update and versioning.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/patient-drug-interactions-handout-and-wallet-card/162153/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/patient-drug-interactions-handout-and-wallet-card/162153.png","ImageObject",442,249,{"name":88,"@type":89},"Bill Black","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/vnd.openxmlformats-officedocument.wordprocessingml.document","2026-09-20","2026-08-30",true,{"@type":98,"interactionType":99,"userInteractionCount":47},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"When must the patient drug interactions handout and wallet card be provided?","Question",{"text":108,"@type":109},"Provide the handout and wallet card at the time of enrollment and when updated.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"Who is responsible for authoring the handout and wallet card for CTEP IND studies?",{"text":113,"@type":109},"For studies under CTEP IND, CTEP PMB authors the handout and wallet card.",{"name":115,"@type":106,"acceptedAnswer":116},"What approval is required before distributing the materials to patients?",{"text":117,"@type":109},"IRB approval is required before distribution to patients.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},162153,1788119428,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":47,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":79,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":125,"read_time":73},24189269381491,"https://ap-avatar.wpscdn.com/avatar/160000cf11732dd8392?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788146458752108895","Patient Drug Interactions Handout and Wallet Card\nA Patient Drug Interactions Handout and Wallet Card must be provided as a protocol appendix for a trial of a non-marketed agent that has potential drug interactions.\nFor studies under CTEP IND, the Handout and Wallet Card will be authored by CTEP PMB.\nFor studies not under CTEP IND, the lead protocol organization is responsible for authoring the Handout and Wallet Card.\nAdditional patient-specific fields in the Handout and Wallet Card are to be filled out by the site with the appropriate information for each patient.\nPlease note the drug interactions handout and wallet card require IRB approval before distribution to patients.\nInstructions to authors: Fill out the appropriate information as instructed by the template.  Use or delete sections below as appropriate.  Only edit the fillable text fields – do not alter any text outside of the fillable fields.  The bracketed instruction text will disappear once you begin typing.\nTemplate: Patient Drug Interactions Handout and a Patient Drug Interactions Wallet Card\nTo be given at the time of enrollment and when updated.\nA protocol that has more than one non-marketed investigational agent with PK interactions will have a drug interactions handout and drug interactions wallet card for each agent.\nAssign a letter or a Roman numeral to the Appendix.\nA convenient wallet-sized information card for the patient to cut out and retain at all times.\nSuggested texts to complete the templates are on the next page.\nUse the fillable template and enter information in the fillable fields.\n\u000f\nTemplate: Patient Drug Interactions Handout and Wallet Card\nAPPENDIX \u0013 FORMTEXT \u0014     \u0015:  PATIENT DRUG Interactions handout and wallet card\nInformation for Patients, Their Caregivers and Non-Study Healthcare Team on Possible Interactions with Other Drugs and Herbal Supplements\nPlease show this paper to all your healthcare providers (doctors, physician assistants, nurse practitioners, pharmacists), and tell them you are taking part in a clinical trial sponsored by the National Cancer Institute.\nThese are the things that your healthcare providers need to know:\n\u0003[Insert study drug]\u0004 interacts with \u0003[certain specific enzyme(s) in your liver or other tissues like the gut]\u0004, \u0003[certain transport proteins that help move drugs in and out of cell]\u0004, \u0003[the heart’s electrical activity (QTc prolongation)]\u0004.\nThese are the things that you need to know:\nThe study drug \u0003[Insert study drug]\u0004, may interact with other drugs which can cause side effects.  For this reason, it is very important to tell your doctors about all your medicines, including:  (a) medicines you are taking before this clinical trial, (b) medicines you start or stop taking during this study, (c) medicines you buy without a prescription (over-the-counter remedy), (d) herbals or supplements (e.g. St. John’s Wort).  It is helpful to bring your medication bottles or an updated medication list with you.\nBefore you enroll onto the clinical trial, your study doctor will work with your regular health care providers to review any medicines and herbal supplements that are considered \u0003[“strong inducers/inhibitors or substrates] of [name(s) of CYP isoenzyme(s)], [transport protein(s), or any medicine associated with greater risk for having QTc prolongation.”]\u0004\nPlease be very careful!  Over-the-counter drugs (including herbal supplements) may contain ingredients that could interact with your study drug.  Speak to your doctors or pharmacist to determine if there could be any side effects.\n\u0003[Add other specific medications here, if necessary. Examples include acid suppressing drugs, NSAIDS, St. John’s Wort.]\u0004\nMake sure your doctor knows to avoid certain prescription medications.\n\u0003[Add other specific medications here, if necessary. Examples include acid suppressing drugs, anticoagulants, NSAIDS.]\u0004\nYour regular health care provider should check a frequently updated medical reference or call your study doctor before prescribing any ","cbCaitRUENySoltX","https://ap.wps.com/l/cbCaitRUENySoltX","docx",50289,"English","# Patient Drug Interactions Handout and Wallet Card\n## Purpose and Distribution Requirements\n## Authorship and Site Responsibilities\n## Template Completion Instructions\n## Appendix Content for Patients and Caregivers","[{\"question\":\"When must the patient drug interactions handout and wallet card be provided?\",\"answer\":\"Provide the handout and wallet card at the time of enrollment and when updated.\"},{\"question\":\"Who is responsible for authoring the handout and wallet card for CTEP IND studies?\",\"answer\":\"For studies under CTEP IND, CTEP PMB authors the handout and wallet card.\"},{\"question\":\"What approval is required before distributing the materials to patients?\",\"answer\":\"IRB approval is required before distribution to patients.\"}]","Patient Drug Interactions Handout and Wallet Card | DOCX"]